JINS HOLDINGS Inc. (JNDOF)
USD 22.75
(0.0%)
USD 22.75
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 56.26 Billion JPY | 7.93% |
| 2022 | 52.13 Billion JPY | 3.41% |
| 2021 | 50.41 Billion JPY | 7.95% |
| 2020 | 46.69 Billion JPY | -1.36% |
| 2019 | 47.34 Billion JPY | 14.2% |
| 2018 | 41.45 Billion JPY | 9.26% |
| 2017 | 37.94 Billion JPY | 9.89% |
| 2016 | 34.52 Billion JPY | 13.86% |
| 2015 | 30.32 Billion JPY | 15.77% |
| 2014 | 26.19 Billion JPY | -4.56% |
| 2013 | 27.44 Billion JPY | 61.3% |
| 2012 | 17.01 Billion JPY | 59.2% |
| 2011 | 10.68 Billion JPY | 42.1% |
| 2010 | 7.52 Billion JPY | 41.03% |
| 2009 | 5.33 Billion JPY | 21.35% |
| 2008 | 4.39 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 15.85 Billion JPY | 13.77% |
| 2024 Q1 | 14.34 Billion JPY | -0.73% |
| 2024 Q2 | 14.57 Billion JPY | 1.57% |
| 2023 Q3 | 14.85 Billion JPY | 10.36% |
| 2023 FY | 56.26 Billion JPY | 7.93% |
| 2023 Q4 | 14.45 Billion JPY | -2.71% |
| 2023 Q1 | 13.49 Billion JPY | 3.79% |
| 2023 Q2 | 13.45 Billion JPY | -0.29% |
| 2022 Q1 | 11.93 Billion JPY | -4.68% |
| 2022 FY | 52.13 Billion JPY | 3.41% |
| 2022 Q4 | 13 Billion JPY | -4.16% |
| 2022 Q3 | 13.57 Billion JPY | -0.38% |
| 2022 Q2 | 13.62 Billion JPY | 14.14% |
| 2021 Q3 | 12.83 Billion JPY | -3.45% |
| 2021 Q4 | 12.52 Billion JPY | -2.44% |
| 2021 Q1 | 11.76 Billion JPY | -16.72% |
| 2021 Q2 | 13.29 Billion JPY | 12.97% |
| 2021 FY | 50.41 Billion JPY | 7.95% |
| 2020 Q3 | 8.13 Billion JPY | -36.35% |
| 2020 Q1 | 11.65 Billion JPY | -9.27% |
| 2020 Q2 | 12.78 Billion JPY | 9.72% |
| 2020 Q4 | 14.12 Billion JPY | 73.65% |
| 2020 FY | 46.69 Billion JPY | -1.36% |
| 2019 FY | 47.34 Billion JPY | 14.2% |
| 2019 Q3 | 12.81 Billion JPY | 13.35% |
| 2019 Q1 | 10.38 Billion JPY | -6.71% |
| 2019 Q2 | 11.3 Billion JPY | 8.91% |
| 2019 Q4 | 12.84 Billion JPY | 0.2% |
| 2018 Q4 | 11.12 Billion JPY | -0.44% |
| 2018 Q1 | 8.91 Billion JPY | -9.07% |
| 2018 Q2 | 10.24 Billion JPY | 14.91% |
| 2018 Q3 | 11.17 Billion JPY | 9.15% |
| 2018 FY | 41.45 Billion JPY | 9.26% |
| 2017 FY | 37.94 Billion JPY | 9.89% |
| 2017 Q4 | 9.8 Billion JPY | -3.42% |
| 2017 Q3 | 10.14 Billion JPY | 6.56% |
| 2017 Q2 | 9.52 Billion JPY | 12.37% |
| 2017 Q1 | 8.47 Billion JPY | -9.37% |
| 2016 FY | 34.52 Billion JPY | 13.86% |
| 2016 Q4 | 9.35 Billion JPY | 2.22% |
| 2016 Q3 | 9.14 Billion JPY | 7.05% |
| 2016 Q2 | 8.54 Billion JPY | 14.15% |
| 2016 Q1 | 7.48 Billion JPY | -12.19% |
| 2015 Q1 | 6.19 Billion JPY | -3.02% |
| 2015 Q4 | 8.52 Billion JPY | -1.17% |
| 2015 Q3 | 8.62 Billion JPY | 23.68% |
| 2015 Q2 | 6.97 Billion JPY | 12.53% |
| 2015 FY | 30.32 Billion JPY | 15.77% |
| 2014 Q4 | 6.39 Billion JPY | -10.18% |
| 2014 FY | 26.19 Billion JPY | -4.56% |
| 2014 Q3 | 7.11 Billion JPY | 5.11% |
| 2014 Q2 | 6.76 Billion JPY | 14.4% |
| 2014 Q1 | 5.91 Billion JPY | -16.81% |
| 2013 Q4 | 7.11 Billion JPY | 2.45% |
| 2013 Q3 | 6.94 Billion JPY | -7.16% |
| 2013 FY | 27.44 Billion JPY | 61.3% |
| 2013 Q1 | 5.9 Billion JPY | 6.61% |
| 2013 Q2 | 7.47 Billion JPY | 26.55% |
| 2012 Q3 | 4.33 Billion JPY | 10.76% |
| 2012 Q4 | 5.54 Billion JPY | 27.84% |
| 2012 FY | 17.01 Billion JPY | 59.2% |
| 2012 Q1 | 3.22 Billion JPY | 8.62% |
| 2012 Q2 | 3.91 Billion JPY | 21.5% |
| 2011 Q4 | 2.96 Billion JPY | 4.58% |
| 2011 Q2 | 2.69 Billion JPY | 23.47% |
| 2011 Q3 | 2.83 Billion JPY | 5.07% |
| 2011 Q1 | 2.18 Billion JPY | 14.98% |
| 2011 FY | 10.68 Billion JPY | 42.1% |
| 2010 Q3 | 2.06 Billion JPY | 4.72% |
| 2010 FY | 7.52 Billion JPY | 41.03% |
| 2010 Q1 | 1.58 Billion JPY | 9.65% |
| 2010 Q4 | 1.9 Billion JPY | -7.86% |
| 2010 Q2 | 1.97 Billion JPY | 24.28% |
| 2009 Q3 | 1.4 Billion JPY | -0.81% |
| 2009 Q1 | 1.06 Billion JPY | 0.0% |
| 2009 Q4 | 1.44 Billion JPY | 2.98% |
| 2009 Q2 | 1.41 Billion JPY | 32.64% |
| 2009 FY | 5.33 Billion JPY | 21.35% |
| 2008 FY | 4.39 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.69 Million USD | -3311227.656% |
| Ansell Limited | 624.8 Million USD | -8904.962% |
| Ansell Limited | 624.8 Million USD | -8904.962% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 113.94 Million USD | -49278.642% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -41659223.979% |
| Psykey, Inc. | 415.97 Thousand USD | -13525439.935% |
| ConvaTec Group Plc | 1.2 Billion USD | -4576.488% |
| ConvaTec Group Plc | 1.17 Billion USD | -4689.156% |
| Encision Inc. | 3.13 Million USD | -1794022.505% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 794.01 Thousand USD | -7085804.135% |
| LifePoint, Inc. | -71.35 Thousand USD | 78846199.947% |
| Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 42948954.962% |
| Paradigm Medical Industries, Inc. | 525 Thousand USD | -10716661.905% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 603.24 Thousand USD | -9326701.936% |
| Reflect Scientific, Inc. | 596.42 Thousand USD | -9433337.119% |
| SmileDirectClub, Inc. | 275.84 Million USD | -20296.452% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | -6146.385% |
| SheerVision, Inc. | 2.17 Million USD | -2585623.943% |
| United Health Products, Inc. | -4857.00 USD | 1158390052.646% |
| Vasamed, Inc. | -69.38 Thousand USD | 81084725.584% |
| Wearable Health Solutions, Inc. | 267.66 Thousand USD | -21019988.694% |
| Yubo International Biotech Limited | 52.65 Thousand USD | -106858139.003% |